首页> 外文期刊>Journal of Traditional Chinese Medical Sciences >Tiaozhi Tongmai Granules reduce atherogenesis and promote the expression of ATP-binding cassette transporter A1 in rabbit atherosclerotic plaque macrophages and the liver
【24h】

Tiaozhi Tongmai Granules reduce atherogenesis and promote the expression of ATP-binding cassette transporter A1 in rabbit atherosclerotic plaque macrophages and the liver

机译:调脂通脉颗粒减少动脉粥样硬化斑块巨噬细胞和肝脏中动脉粥样硬化的发生并促进ATP结合盒转运蛋白A1的表达

获取原文
           

摘要

Objective ATP-binding cassette transporter A1 (ABCA1) is an integral membrane protein that plays a key role in cellular lipid metabolism, preventing the accumulation of lipids that contribute to the initiation and progression of atherosclerosis. Tiaozhi Tongmai Granules are a Chinese herbal compound that is capable of treating atherosclerosis. This study was designed to explore the potential pharmacological mechanism by which Tiaozhi Tongmai Granules protect against atherosclerosis. Methods Forty-nine male New Zealand rabbits were randomly divided into seven groups: normal control group, normal diet; model groups 1 and 2: balloon injury and high-fat diet for 6 or 12 weeks; statin groups 1 and 2: balloon injury and high-fat diet plus atorvastatin for 6 or 12 weeks; and Chinese herb groups 1 and 2: balloon injury and high-fat diet plus Tiaozhi Tongmai Granules for 6 or12 weeks. The granules were administered at a dose of 1.14?g/kg/d, with atorvastatin (1.14?mg/kg/d) serving as positive control. Serum lipid profiles and liver function indices were measured. Atherogenesis was viewed after H&E staining and quantified by thickened intimal area percentage and maximal intimal thickness percentage. The ABCA1 protein expression in atherosclerotic plaque macrophages of the common carotid arteries (CCA), thoracic aortae (TA), and liver tissues were observed by immunohistochemical staining and evaluated using mean optical density (OD) value in macrophages and ABCA1-positive hepatocyte number. Results Compared with model group 1 at week 6, Chinese herb group 1 and statin group 1 displayed significant reductions in total cholesterol (TC) ( P ?=?0.027, 0.012) and low-density lipoprotein cholesterol (LDL-C) ( P ?=?0.039, 0.028) levels, as well as marked increases in ABCA1-positive hepatocyte numbers ( P all <0.001), and only statin group 1 displayed a markedly reduced maximal intimal thickness percentage in the CCA ( P ?=?0.018). Compared with model group 2 at week 12, Chinese herb group 2 and statin group 2 all presented significant reductions in TC ( P ?=?0.011, 0.003), LDL-C ( P ?=?0.017, 0.010) and thickened intimal area percentage in the CCA ( P ?=?0.001, 0.022), as well as prominent increases in the ABCA1 OD value of both the CCA ( P ?=?0.001, 0.039) and TA ( P ?=?0.001, 0.025) and positive hepatocyte number ( P all <0.001). Chinese herb group 2 had a markedly reduced maximal intimal thickness percentage compared with model group 2 ( P ?=?0.006) and a higher positive hepatocytes number than statin group 2 ( P ?=?0.001). Conclusions Tiaozhi Tongmai Granules appear to have an anti-atherogenic effect that is most likely mediated by simultaneously upregulating the protein expression of ABCA1 in rabbit atherosclerotic plaque macrophages and in the liver.
机译:目的ATP结合盒转运蛋白A1(ABCA1)是一种不可或缺的膜蛋白,在细胞脂质代谢中起关键作用,防止脂质积聚,这些脂质有助于动脉粥样硬化的发生和发展。调脂通脉颗粒是一种中草药化合物,能够治疗动脉粥样硬化。本研究旨在探讨调脂通脉颗粒预防动脉粥样硬化的潜在药理机制。方法将49只雄性新西兰兔随机分为七组:正常对照组,正常饮食;模型1和2组:气球损伤和高脂饮食6或12周;他汀类药物第1组和第2组:球囊损伤和高脂饮食加阿托伐他汀治疗6或12周;中草药组1和2:气囊损伤和高脂饮食加调脂通脉颗粒剂治疗6或12周。以1.14μg/ kg / d的剂量给予该颗粒,以阿托伐他汀(1.14μg/ kg / d)作为阳性对照。测量血清脂质谱和肝功能指数。 H&E染色后观察动脉粥样硬化的发生,并通过增厚的内膜面积百分比和最大内膜厚度百分比进行量化。通过免疫组织化学染色观察在颈总动脉(CCA),胸主动脉(TA)和肝组织的动脉粥样硬化斑块巨噬细胞中的ABCA1蛋白表达,并使用巨噬细胞中的平均光密度(OD)值和ABCA1阳性肝细胞数量进行评估。结果与模型组1在第6周相比,中草药组1和他汀类药物组1的总胆固醇(TC)显着降低(P = 0.027,0.012),低密度脂蛋白胆固醇(LDL-C)降低(P? =?0.039,0.028)水平,以及ABCA1阳性肝细胞数量显着增加(P all <0.001),只有他汀类药物组1在CCA中显示最大内膜厚度百分比显着降低(P?=?0.018)。与模型组2在第12周相比,中药组2和他汀类药物组2均显着降低TC(P = 0.011,0.003),LDL-C(P = 0.017,0.010)和内膜面积百分比增高CCA(P = 0.001,0.022)和PCA的ABCA1 OD值显着增加(P = 0.001,0.039)和TA(P = 0.001,0.025)和阳性肝细胞数字(P全部<0.001)。与模型组2相比,中药组2的最大内膜厚度百分比显着降低(P = 0.006),阳性肝细胞数比他汀2组更高(P = 0.001)。结论调脂通脉颗粒似乎具有抗动脉粥样硬化作用,这很可能是通过同时上调兔动脉粥样斑块巨噬细胞和肝脏中ABCA1的蛋白表达来介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号